Sunday , October 22 2017
Home / Resources / Exclusive Interviews / Beta-Cell Construct: Egregious Eleven

Beta-Cell Construct: Egregious Eleven

stanley_schwartzIn part two of this special interview with DIC publisher Steve Freed, Dr. Stanley Schwartz discusses the “egregious eleven” — six mechanisms that injure the beta cell, and five results of injury — and the role they play in hyperglycemia.

 

Fill out my online form.
Use Wufoo integrations and get your data to your favorite apps.

View the complete video series of this special interview with Dr. Schwartz:

Part 1: Defining the Classifications of the New System

Part 2: Beta-Cell Construct: Egregious Eleven

Part 3: Targeted Treatments for Mediating Pathways of Hyperglycemia

Part 4: Individualization of Patient Care

Part 5: The Beta-Cell is Final Common Denominator of Beta-Cell Damage

Part 6: New Classification for Monogenic and Pre-Diabetes

Part 7: Supporters of New Classification of Diabetes

You can find all of Dr. Schwartz’s Diabetes In Control articles and videos as well as his biography here.